The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / February / The 5Hour Sepsis Test No Cultures Required
Microbiology & Immunology Infectious Disease Biochemistry and molecular biology Clinical care Point of care testing Omics Technology and innovation Research and Innovations

The 5-Hour Sepsis Test: No Cultures Required

Rapid culture-free test results are consistent with the gold standard for sepsis detection

By Helen Bristow 02/04/2026 Interview 5 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll

Share

Clinical Scorecard: The 5-Hour Sepsis Test: No Cultures Required

At a Glance

CategoryDetail
ConditionSepsis
Key MechanismsCulture-free blood test using pan-pathogen PCR and nanopore sequencing to detect intact bacterial cells.
Target PopulationICU patients with suspected sepsis.
Care SettingIntensive Care Unit (ICU)

Key Highlights

  • Culture-free assay detected 50% of tests positive compared to 12% for blood cultures.
  • Sensitivity of the culture-free assay was close to 95% with a negative predictive value of 98%.
  • Median turnaround time for results was just over 5 hours, significantly faster than conventional methods.

Guideline-Based Recommendations

Diagnosis

  • Utilize culture-free assay for rapid identification of pathogens in suspected sepsis cases.

Management

  • Integrate rapid test results with clinical context for timely therapeutic adjustments.

Monitoring & Follow-up

  • Monitor for concordance between culture-free assay results and site-specific microbiological findings.

Risks

  • Consider the potential for false positives or negatives, especially with fastidious organisms.

Patient & Prescribing Data

Patients in the ICU with suspected sepsis requiring rapid microbiological confirmation.

Early identification of pathogens can reduce unnecessary broad-spectrum antibiotic use.

Clinical Best Practices

  • Read culture-free assay results within a clinical–microbiological framework.
  • Correlate findings with site-of-infection microbiology and blood culture results.

Related Resources & Content

  • Sepsis Update Congress 2025

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Helen Bristow

Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.

More Articles by Helen Bristow

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.